Despite American Diabetes Association and APA recommendations of glucose and lipid testing for all patients started on antipsychotics, there is a disconnect between prescribing of antipsychotics and metabolic screening with most psychiatrists and physicians agreeing that psychiatrists should not treat metabolic problems, according to a study presented Monday at the APA convention in Philadelphia.
Baseline Lipid Monitoring with Antipsychotics “Disappointingly Low” (MadinAmerica.com)
Rates of Metabolic Screening Remain Low in Children Taking Antipsychotics (Medscape Today)
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.